The antifibrinolytic properties of XXXX .

@entity1 @entity1066 @entity4444 @entity2275
The mucosal fibrinolytic activity was estimated in 24 @entity1 with duodenal @entity1066 and in 11 @entity1 with @entity2275 . The fibrinolytic activity was estimated in biopsy specimens taken during gastroscopy. Specimens were taken in the corpus, in the antrum, and in the duodenal mucosa. In @entity1 with duodenal @entity1066 the fibrinolytic activity was significantly higher in the corpus and antrum mucosa, whereas no difference was observed in the duodenal mucosa compared with controls. Gastric @entity1066 @entity1 had, compared with controls, significantly higher activity in the corpus mucosa only. Fourteen @entity1 with duodenal @entity1066 and five with @entity2275 were treated with 1 g @entity4444 daily for 4 weeks. The mucosal fibrinolytic activity was estimated before and after treatment in the above-mentioned regions. A significant reduction was observed after treatment in @entity1 with duodenal @entity1066 , both in the corpus and in the duodenal mucosa, whereas no difference was seen in the duodenum. In @entity1 with @entity2275 a reduction was observed in the corpus mucosa only. The fibrinolytic activity estimated was plasminogen activator, and not other proteases, in all estimations.
